Skip to content

Acupuncture therapies for relieving pain in pelvic inflammatory disease: A systematic review and meta-analysis

Yi et al. · PLOS ONE · 2024

📊Systematic Review and Meta-analysis👥n=1,165 participants⚠️Low-quality evidence
🎯

OBJECTIVE

Evaluate efficacy and safety of acupuncture for pain relief in pelvic inflammatory disease (PID)

👥

WHO

1,165 women with acute or chronic PID

⏱️

DURATION

7 to 60 treatment sessions

📍

POINTS

Guanyuan (CV-4 关元), Qihai (CV-6 气海), Sanyinjiao (SP-6 三阴交), Shenshu (BL-23 肾俞), Zigong (EX-CA1 子宫)

🔬 Study Design

1165participants
randomization

Acupuncture + Standard Treatment

n=819

Acupuncture combined with antibiotics/analgesics

Acupuncture Alone

n=186

Manual acupuncture, electroacupuncture, or moxibustion

Control

n=1165

Conventional treatment only

⏱️ Duration: Variable, from 7 to 60 sessions

📊 Results in numbers

0

Abdominal pain reduction (VAS)

0

Lumbosacral pain reduction (VAS)

0

Sustained effect at 1 month

0

IL-6 reduction (anti-inflammatory)

0

IL-2 increase (immunomodulation)

📊 Outcome Comparison

Visual Analog Scale - Abdominal Pain

Acupuncture
6.8
Control
8.12

Adverse Events (%)

Acupuncture
0
Control
6
💬 What does this mean for you?

This research showed that acupuncture can significantly reduce pelvic and abdominal pain in women with pelvic inflammation. Pain relief persisted for at least one month after treatment. Acupuncture also reduced inflammation in the body and did not cause major side effects, and was considered safe.

📝

Article summary

Plain-language narrative summary

Pelvic inflammatory disease (PID) is a condition that affects millions of women worldwide, characterized by inflammation in the female reproductive organs, including the uterus, fallopian tubes, ovaries, and pelvic peritoneum. This condition represents a significant public health problem, with annual costs exceeding 4 billion dollars in the United States alone. The main symptom of PID is abdominal or pelvic pain, which can progress to chronic pelvic pain, one of the most frequent and debilitating complications. This persistent pain not only affects patients' quality of life but can also lead to psychological problems such as anxiety and depression.

Although conventional treatments include broad-spectrum antibiotics, their long-term efficacy is often limited, leaving patients with chronic pain that requires complementary treatment approaches.

This study aimed to evaluate the efficacy and safety of acupuncture therapies as complementary or alternative treatments for pain relief in patients with PID. The researchers conducted a systematic review and meta-analysis following rigorous international scientific standards. To do so, they performed a comprehensive search across eight medical databases, including both international and Chinese sources, covering publications from the inception of these databases through February 2023. Only randomized controlled clinical trials investigating different types of acupuncture, such as manual acupuncture, electroacupuncture, warm needling, and other related techniques, were included.

The researchers primarily evaluated abdominal and lumbosacral pain intensity scores using validated scales such as the visual analog scale. They also analyzed important secondary outcomes, including blood levels of inflammatory substances, anxiety scores, and quality of life.

The final analysis included 12 clinical trials conducted between 2016 and 2023, involving a total of 1,165 patients, all conducted in China. The results demonstrated that acupuncture, whether used alone or combined with conventional medical treatment, was significantly more effective than conventional treatment alone in reducing abdominal pain. This pain improvement remained evident for at least one month after the end of treatment, suggesting durable benefits. Acupuncture also showed superior efficacy in reducing lumbosacral pain associated with PID.

Beyond pain benefits, the study revealed that acupuncture produced important anti-inflammatory effects, increasing the levels of substances that combat inflammation (such as IL-2) and decreasing those that promote inflammation (such as IL-6 and TNF-α). The researchers also observed significant improvements in patients' anxiety levels and overall quality of life. Regarding safety, acupuncture did not increase the incidence of adverse effects compared with conventional treatment, and when they occurred, they were mild and self-limited.

For patients suffering from PID-related pain, these results suggest that acupuncture may be a valuable and safe therapeutic option, especially when used as a complement to conventional medical treatment. Acupuncture's ability to provide durable pain relief, reduce inflammation, and improve psychological well-being offers a holistic approach to managing this complex condition. For healthcare professionals, the study provides evidence that incorporating acupuncture into treatment plans can enhance therapeutic outcomes without compromising safety. The absence of significant adverse effects makes this therapy particularly attractive for patients seeking alternatives to pain medications or who experience side effects with conventional treatments.

The findings also highlight the potential of integrative medicine, where complementary therapies work in synergy with standard medical treatments.

It is important to recognize several limitations of this study that should be considered when interpreting the results. All included studies were conducted in China, which may limit the applicability of the findings to other populations and healthcare systems. In addition, the individual studies had relatively small samples and variable methodological quality, resulting in evidence rated as low to very low quality according to rigorous scientific criteria. The inability to fully blind acupuncture treatments (since both patients and providers knew they were receiving acupuncture) may have influenced the results.

The study also identified significant variability among the different acupuncture techniques used and in the selection of specific points, making it difficult to determine which approach is most effective. Although promising, these results should be interpreted with caution, and additional studies of higher methodological quality, with larger samples and conducted in different countries, are needed to definitively confirm the efficacy of acupuncture in treating PID-related pain and to establish standardized treatment protocols.

Strengths

  • 1First systematic review on acupuncture for PID pain
  • 2Large number of participants (1,165 women)
  • 3Demonstrated measurable anti-inflammatory effects
  • 4Evidence of safety with low adverse events
  • 5Durable effects for at least 1 month
⚠️

Limitations

  • 1All studies conducted only in China
  • 2High heterogeneity across studies
  • 3Low methodological quality of included studies
  • 4Small samples in individual studies
  • 5Possible publication bias detected
Dr. Marcus Yu Bin Pai

Expert Commentary

Dr. Marcus Yu Bin Pai

MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

Clinical Relevance

Chronic pelvic pain secondary to pelvic inflammatory disease represents one of the most frustrating scenarios in outpatient management, precisely because the antibiotic course resolves the infection but leaves the patient with a residual inflammatory substrate that conventional analgesics control only partially. This meta-analysis, gathering 1,165 women, provides the first quantitative synthesis showing that acupuncture — alone or as an adjunct to standard treatment — reduces abdominal pain scores by 1.32 points and lumbosacral scores by 1.14 points on the VAS, with an effect that persists for at least one month. For physiatry and pain medicine, this positions acupuncture as a legitimate adjunct in the multimodal arsenal for these patients, particularly those with post-PID chronic pelvic pain syndrome, NSAID intolerance, or documented anxiety component — a subgroup in which the meta-analysis also showed benefit on anxiety scores and quality of life.

Notable Findings

The most striking finding is not the pain reduction itself but the documented immunomodulatory profile: a 2.59-point drop in IL-6 levels and a 1.60-point increase in IL-2. This pattern suggests that acupuncture acts on the pelvic inflammatory microenvironment in a mechanistically relevant way, shifting the cytokine balance from a pro-inflammatory state toward resolution — which would explain, at least in part, the durability of the analgesic effect beyond the active treatment period. The even more pronounced pain reduction at one-month follow-up (-1.44 on the VAS) compared with the immediate outcome is unusual in pain-intervention meta-analyses and deserves attention: it suggests that the effect does not decay with treatment withdrawal, which has direct implications for maintenance frequency. The safety profile, with mild and self-limited adverse events, reinforces the feasibility of continued use.

From My Experience

In my practice in the chronic pelvic pain clinic, I have been treating women with painful PID sequelae for more than two decades, and the pattern I observe is quite consistent with the findings of this review. I usually note an initial clinical response — at least 30% reduction on the VAS — between the third and fifth sessions, especially when I combine manual acupuncture with electroacupuncture at points along the lumbosacral region and the spleen meridian. For these patients, I typically work with protocols of 10 to 12 sessions in the acute phase of complementary treatment, followed by monthly maintenance for three to six months. I routinely combine this with pelvic physical therapy and, when there is an evident lumbopelvic myofascial component, I incorporate dry needling of the iliopsoas and lumbar paravertebral trigger points. The patient profile that responds best, in my experience, is the young woman with recurrent PID, predominantly diffuse pain, and high kinesiophobia scores — exactly the subgroup in which the psychological benefit reported in this meta-analysis makes the most clinical sense.

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Full original article

Read the full scientific study

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0292166

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.